Severe community-acquired pneumonia

Clinics in Chest Medicine

Volumn 20, Issue 3, 1999, Pages 575-587

  Ewig, S ^a   Torres, A ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; ANTIINFLAMMATORY AGENT; BETA LACTAMASE INHIBITOR; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; IMIPENEM; MACROLIDE; PROSTACYCLIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TOBRAMYCIN;

AEROSOL; AGING; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIMICROBIAL THERAPY; CAUSE OF DEATH; COMORBIDITY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ELDERLY CARE; HUMAN; IMMUNOMODULATION; INTENSIVE CARE UNIT; NURSING HOME; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

EID: 0032878566     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70237-9     Document Type: Article

References (72)

1. M. Alkhayer P.F. Jenkins B.D. Harrison The outcome of community-acquired pneumonia treated on the intensive care unit Respir Med 84 1990 13
2. J. Almirall E. Mesalles J. Klamburg Prognostic factors of pneumonia requiring admission to the intensive care unit Chest 107 1995 511
3. J. Almirall I. Morato F. Riera Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: A prospective multicentre study Eur Respir J 6 1993 14
4. American Thoracic Society Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy Am Rev Respir Dis 148 1993 1418
5. F. Bella J. Tort M.A. Morera Value of bacterial antigen detection in the diagnostic yield of transthoracic needle aspiration in severe community-acquired pneumonia Thorax 48 1993 1227
6. W.G. Boersma A. Löwenberg Y. Holloway Pneumococcal capsular antigen detection and pneumococcal serology in patients with community-acquired pneumonia Thorax 46 1991 902
7. A. Brett D.G. Sinclair Use of continuous positive airway pressure in the management of community-acquired pneumonia Thorax 48 1993 1280
8. British Thoracic Society and the Public Health Laboratory Service Community-acquired pneumonia in adults in British hospitals in 1982–1983: A survey of aetiology, mortality, prognostic factors and outcome Q J Med 239 1987 195
9. British Thoracic Society Research Committee and The Public Health Laboratory Service The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit Respir Med 86 1992 7
10. A. Bryskier New concepts in the field of cephalosporins: C-3′ quaternary ammonium cephems (group IV) Clin Microbiol Infect 3 suppl 1 1997
11. R. Cosentini F. Blasi R. Raccanelli Severe community-acquired pneumonia: a possible role for Chlamydia pneumoniae. Respiration 63 1996 61
12. B.P. deBoisblanc C.M. Mason J. Andresen Phase 1 safety trial of filgrastim (r-metHuG-CSF) in non-neutropenic patients with severe community-acquired pneumonia Respir Med 91 1997 387
13. D. Dreyfuss K. Djedaini J.J. Lanore A comparative study of the effects of almitrine bimesylate and lateral position during unilateral bacterial pneumonia with severe hypoxemia Am Rev Respir Dis 146 1992 295
14. I.J. Dunn T.J. Marrie A.D. MacKeen The value of open lung biopsy in immunocompetent patients with community-acquired pneumonia requiring hospitalization Chest 106 1994 23
15. European study on community-acquired pneumonia (ESOCAP) committee Guidelines for management of adult community-acquired lower respiratory tract infections Eur Respir J 11 1998 986
16. S. Ewig Community-acquired pneumonia. Epidemiology, risk, and prognosis A. Torres M. Woodhead European Respiratory Monograph: Pneumonia 1997 European Respiratory Society Journals, Ltd. Sheffield, UK
17. S. Ewig T. Bauer E. Hasper Prognostic analysis and predictive rule for outcome of hospital-treated community-acquired pneumonia Eur Respir J 8 1995 392
18. Ewig S, Kleinfeld T, Bauer T, et al: Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population. Thorax 1998, submitted
19. S. Ewig M. Ruiz J. Mensa Severe community-acquired pneumonia—assessment of severity criteria Am J Respir Crit Care Med 158 1998 1102 1108
20. V. Falco T. Fernandez de Sevilla Legionella pneumophila. A cause of severe community-acquired pneumonia Chest 100 1991 1007
21. B.M. Farr D.L. Kaiser B.D.W. Harrison Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features Thorax 44 1984 1031
22. B.M. Farr A.J. Sloman M.J. Fisch Predicting death in patients hospitalized for community-acquired pneumonia Ann Intern Med 115 1991 428
23. S.H. Feinsilver A.M. Fein M.S. Niederman Utility of fiberoptic bronchoscopy in nonresolving pneumonia Chest 98 1990 1322
24. C. Feldman J.M. Kallenbach H. Levy Community-acquired pneumonia of diverse etiology: Prognostic features in patients admitted to an intensive-care unit and a “severity of illness” score Intensive Care Med 15 1989 302
25. C. Feldman S. Ross A. Goolam Mahomed The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial treatment Respir Med 89 1995 187
26. M. Ferrer A. Torres R. Baer Effect of acetylsalicylic acid on pulmonary gas exchange in patients with severe pneumonia. A pilot study Chest 111 1997 1094
27. M.J. Fine M.A. Smith C.A. Carson Prognosis and outcome of patients with community-acquired pneumonia: A meta-analysis JAMA 275 1996 134
28. M.P. Fink D.R. Snydman M.S. Niederman Treatment of severe pneumonia in hospitalized patients: Results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin Antimicrob Agents Chemother 38 1994 547
29. J. Gea J. Roca A. Torres Mechanisms of abnormal gas exchange in patients with pneumonia Anesthesiology 75 1991 782
30. F.P. Gomez R. Iglesia A. Torres Nitric oxide inhalation in severe pneumonia Eur Respir J 10 suppl 25 1997 21s
31. A. Granados D. Podzamczer F. Gudiol Pneumonia due to Legionella pneumoniae and pneumococcal pneumonia: Similarities and differences on presentation Eur Respir J 2 1989 130
32. P.J. Hanly D. Roberts K. Dobson Effect of indomethacin on arterial oxygenation in critically ill patients with severe bacterial pneumonia Lancet 1 1987 351
33. P. Jimenez F. Saldias M. Meneses Diagnostic fiberoptic bronchoscopy in patients with community-acquired pneumonia. Comparison between bronchoalveolar lavage and telescoping plugged catheter cultures Chest 103 1993 1023
34. C. Jokinen H. Heiskanen H. Juvonen Incidence of community-acquired pneumonia in the population of four municipalities in Eastern Finland Am J Epidemiol 137 1993 977
35. G.M. Jong T.R. Hsiue C.R. Chen Rapidly fatal outcome of bacteremic Klebsiella pneumoniae pneumonia in alcoholics Chest 107 1995 214 217
36. N.C. Karalus R.T. Cursons R.A. Leng Community acquired pneumonia: Aetiology and prognostic index evaluation Thorax 46 1991 413
37. I. Koivula M. Sten P.H. Makela Risk factors for pneumonia in the elderly Am J Med 96 1994 313
38. O. Leroy H. Georges C. Beuscart Severe community-acquired pneumonia in ICUs: Prospective validation of a prognostic score Intensive Care Medicine 22 1996 1307
39. O. Leroy C. Santre C. Beuscart A 5-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit Intensive Care Medicine 21 1995 24
40. J.T. Macfarlane A.C. Miller W.H.R. Smith Comparative radiographic features of community acquired legionnaires' disease, pneumococcal pneumonia, Mycoplasma pneumonia and psittacosis Thorax 39 1984 28
41. T.J. Marrie H. Durant L. Yates Community-acquired pneumonia requiring hospitalisation: 5-year prospective study Rev Infect Dis 11 1989 586
42. P. Moine J.B. Vercken S. Chevret Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors Chest 105 1994 1487
43. P. Moine J.B. Vercken S. Chevret Severe community-acquired pneumococcal pneumonia Scand J Infect Dis 27 1995 201
44. A.M. Neill I.R. Martin R. Weir Community-acquired pneumonia: Aetiology and usefulness of severity criteria on admission Thorax 51 1996 1010
45. S. Nelson W. Summer G. Bagby Granulocyte colony-stimulating factor enhances pulmonary host defences in normal and ethanol-treated rats J Infect Dis 164 1991 901
46. P.M. Oleachea J.M. Quintana M.S. Gallardo A predictive model for the treatment approach to community-acquired pneumonia in patients needing ICU admission Intensive Care Medicine 22 1996 1294
47. A. Örtquist M. Kalin L. Leideborn Diagnostic fiberoptic bronchoscopy and protected brush culture in patients with community-acquired pneumonia Chest 97 1990 576
48. A. Örtquist G. Sterner J.A. Nilsson Severe community-acquired pneumonia: Factors influencing need of intensive care treatment and prognosis Scand J Infect Dis 17 1985 377
49. W. Osler The Principles and Practices of Medicine ed. 1 1892 Appleton New York
50. J. Pachon M.D. Prado F. Capote Severe community-acquired pneumonia Am Rev Respir Dis 142 1990 369
51. P.D. Potgrieter J.M.J. Hammond Etiology and diagnosis of pneumonia requiring ICU admission Chest 101 1992 199
52. P.D. Potgieter J.M.J. Hammond The intensive care management, mortality and prognostic indicators in severe community-acquired pneumococcal pneumonia Intensive Care Medicine 22 1996 1301
53. H.A. Reimann An acute infection of the respiratory tract with atypical pneumonia JAMA 11 1938 2377
54. J. Rello E. Quintana V. Ausina A 3-year study of severe community-acquired pneumonia with emphasis on outcome Chest 103 1993 232
55. J. Rello R. Rodriguez P. Jubert Severe community-acquired pneumonia in the elderly: Epidemiology and prognosis Clin Infect Dis 23 1996 723
56. R. Riquelme A. Torres M. El-Ebiary Community-acquired pneumonia in the elderly: Etiology, risk, and prognostic factors Am J Respir Crit Care Med 154 1996 1450
57. R. Rodriguez-Roisin J. Roca Update '96 on pulmonary gas exchange pathophysiology in pneumonia Semin Respir Infect 11 1996 3
58. R. Roissant K.J. Falke F. Lopez Inhaled nitric oxide in adult respiratory distress syndrome N Engl J Med 328 1993 399
59. B. Ruf D. Schürmann I. Horbach Prevalence and diagnosis of Legionella pneumonia. A 3-year prospective study with emphasis on urinary antigen detection J Infect Dis 162 1990 1341
60. Ruiz M. Ewig S. Marcos M.A. Etiology of community-acquired pneumonia in hospitalized patients—impact of age, comorbidity, and severity Am J Respir Crit Care Med 1999 in press
61. B. Satapatayavongs R.B. Kohler L.J. Wheat Rapid diagnosis of Legionnaires' disease by latex agglutination Am Rev Respir Dis 127 1983 559
62. S.J. Skerrett Diagnostic testing to establish a microbial cause is helpful in the management of community-acquired pneumonia Semin Respir Infect 12 1997 308
63. Y.K. Tan K.L. Khoo S.P. Chin Aetiology and outcome of severe community-acquired pneumonia in Singapore Eur Respir J 12 1998 113
64. A. Torres J.P. De La Bellacasa A. Xaubet Diagnostic value of quantitative cultures of bronchoalveolar lavage and telescoping plugged catheters in mechanically ventilated patients with bacterial pneumonia Am Rev Respir Dis 140 1989 306
65. A. Torres P. Jimenez Puig de la Bellacasa Diagnostic value of nonfluoroscopic percutaneous lung needle aspiration in patients with pneumonia Chest 98 1990 840
66. A. Torres J. Serra-Batlles A. Ferrer Severe community-acquired pneumonia. Epidemiology and prognosis factors Am Rev Respir Dis 114 1991 312
67. D. Walmrath T. Schneider J. Pilch Effects of aerosolized prostacyclin in severe pneumonia: Impact of fibrosis Am J Respir Crit Care Med 151 1995 724
68. M.A. Woodhead J.T. Macfarlane Comparative clinical and laboratory features of Legionella with pneumococcal and mycoplasmal pneumonias Br J Dis Chest 81 1987 133
69. M.A. Woodhead J.T. McFarlane J.S. McCracken Prospective study of the aetiology and outcome of pneumonia in the community Lancet 1 1987 671
70. M.A. Woodhead J.T. McFarlane F.G. Rodgers Aetiology and outcome of severe community-acquired pneumonia J Infect 10 1985 204
71. M.A. Woodhead J. Radvan J.T. Macfarlane Adult community-acquired staphylococcal pneumonia in the antibiotic era: A review of 61 cases Q J Med 245 1987 783
72. R.G. Wunderink K.V. Leeper R.M.H. Schein Clinical response to filgrastim (r-metHuG-CSF) in pneumonia with severe sepsis Am J Respir Crit Care Med 153 1996 A123